This is a phase 2a clinical trial performed to evaluate the efficacy of a topical treatment of ibuprofen compared to the use of a placebo topical treatment. A multi-center, double-blinded, randomized placebo controlled study. Study length: 14 days Dosing twice daily (b.i.d.)
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
75
Unnamed facility
Sankt Gallen, Switzerland
Unnamed facility
Schaffhausen, Switzerland
Unnamed facility
Zurich, Switzerland
Unnamed facility
Zurich, Switzerland
Rheumaklinik und Institut für Physikalische Medizin Universitätsspital
Visual Analogue Scale (VAS) Pain scale
Time frame: 14 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Zurich, Switzerland